miR-324-5p and miR-30c-2-3p Alter Renal Mineralocorticoid Receptor Signaling under Hypertonicity
Thi An Vu,
Ingrid Lema,
Imene Hani,
Lydie Cheval,
Laura Atger-Lallier,
Vilayvane Souvannarath,
Julie Perrot,
Mélanie Souvanheuane,
Yannick Marie,
Sylvie Fabrega,
Anne Blanchard,
Jérôme Bouligand,
Peter Kamenickỷ,
Gilles Crambert,
Laetitia Martinerie,
Marc Lombès,
Say Viengchareun
Affiliations
Thi An Vu
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Ingrid Lema
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Imene Hani
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Lydie Cheval
Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris Cité, 75006 Paris, France
Laura Atger-Lallier
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Vilayvane Souvannarath
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Julie Perrot
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Mélanie Souvanheuane
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Yannick Marie
Plateforme de Genotypage Séquençage (iGenSeq), Institut du Cerveau et de la Moelle Epinière, Hôpital Sapêtrière, 75013 Paris, France
Sylvie Fabrega
Plateforme Vecteurs Viraux et Transfert de Gènes, Structure Federative de Recherche Necker, UMS 24, UMS 3633, Faculté de Santé, Université Paris Cité, 75015 Paris, France
Anne Blanchard
Inserm, Centre d’Investigations Cliniques 9201, 75015 Paris, France
Jérôme Bouligand
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Peter Kamenickỷ
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Gilles Crambert
Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris Cité, 75006 Paris, France
Laetitia Martinerie
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Marc Lombès
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
Say Viengchareun
Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, 94276 Le Kremlin-Bicêtre, France
The Mineralocorticoid Receptor (MR) mediates the sodium-retaining action of aldosterone in the distal nephron, but mechanisms regulating MR expression are still poorly understood. We previously showed that RNA Binding Proteins (RBPs) regulate MR expression at the post-transcriptional level in response to variations of extracellular tonicity. Herein, we highlight a novel regulatory mechanism involving the recruitment of microRNAs (miRNAs) under hypertonicity. RT-qPCR validated miRNAs candidates identified by high throughput screening approaches and transfection of a luciferase reporter construct together with miRNAs Mimics or Inhibitors demonstrated their functional interaction with target transcripts. Overexpression strategies using Mimics or lentivirus revealed the impact on MR expression and signaling in renal KC3AC1 cells. miR-324-5p and miR-30c-2-3p expression are increased under hypertonicity in KC3AC1 cells. These miRNAs directly affect Nr3c2 (MR) transcript stability, act with Tis11b to destabilize MR transcript but also repress Elavl1 (HuR) transcript, which enhances MR expression and signaling. Overexpression of miR-324-5p and miR-30c-2-3p alter MR expression and signaling in KC3AC1 cells with blunted responses in terms of aldosterone-regulated genes expression. We also confirm that their expression is increased by hypertonicity in vivo in the kidneys of mice treated with furosemide. These findings may have major implications for the pathogenesis of renal dysfunctions, sodium retention, and mineralocorticoid resistance.